Raclopride tartrate
Raclopride tartrate structure
|
Common Name | Raclopride tartrate | ||
|---|---|---|---|---|
| CAS Number | 98185-20-7 | Molecular Weight | 497.32400 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H26Cl2N2O9 | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
|
Effect of raclopride on dopamine D2 receptor mRNA expression in rat brain.
Neuroscience 47 , 771-779, (1992) Prolonged treatment with dopamine D2 receptor antagonists is known to elevate the density of dopamine D2 receptor binding sites in caudate-putamen and nucleus accumbens in rat and human brain. In this study we used the dopamine D2 receptor antagonist raclopri... |
|
|
Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity.
Psychopharmacology 112 , 389-397, (1993) The effects of chronic treatment with dopamine (DA) D1 and D2 receptor antagonists were evaluated in eight cebus apella monkeys with mild oral dyskinesia after previous haloperidol treatment. SCH 23390 (D1 antagonist) was given daily to investigate the direct... |
|
|
Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.
Eur. J. Pharmacol. 271 , 167, (1994) S 14506 (1-[-(4-fluorobenzoylamino)ethyl]-4-(7-methoxynaphthyl)piper azine hydrochloride), 8-OH-DPAT ((+/-)-8-hydroxydipropylaminotetralin hydrobromide), clozapine and raclopride were compared in some behavioural models able to characterize dopamine antagonis... |